Summary:
Market Analysis and Insights: Global Prothrombin Complex Concentrate(PCC) Market
Mainly used to treat congenital and acquired coagulation factor II, VII, IX, and X deficiencies (alone or in combination) including: coagulation factor IX deficiency (hemophilia B), and coagulation factor II, VII, X deficiency overdose of anticoagulants, vitamin K deficiency; patients with hemorrhage caused by liver disease need to correct coagulation dysfunction; when disseminated intravascular coagulation (DIC) occurs, coagulation factors II, VII, IX, and X are consumed in large quantities, which can be used in heparin Application after chemotherapeutic; prothrombin time prolongation due to various reasons and intended for surgery, but may be ineffective for those with coagulation factor V deficiency; treatment of bleeding symptoms in patients with hemophilia A who have produced factor VIII preparations ; Reversal of coumarin anticoagulant-induced bleeding.
Due to the COVID-19 pandemic, the global Prothrombin Complex Concentrate(PCC) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 100IU accounting for % of the Prothrombin Complex Concentrate(PCC) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hopistial segment is altered to an % CAGR throughout this forecast period.
China Prothrombin Complex Concentrate(PCC) market size is valued at US$ million in 2021, while the US and Europe Prothrombin Complex Concentrate(PCC) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Prothrombin Complex Concentrate(PCC) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Prothrombin Complex Concentrate(PCC) include CSL, Beijing Tiantan Biological Products, SHANGHAI RAAS, Biotest, Taibang Biologic Group, HUALAN BIOLOGICAL ENGINEERING, WEIGUANG BIOLOGICAL, Green Cross and BOHUI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
100IU
200IU
300IU
400IU
1000IU
Segment by Application
Hopistial
Clinic
Others
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Prothrombin Complex Concentrate(PCC) market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
CSL
Beijing Tiantan Biological Products
SHANGHAI RAAS
Biotest
Taibang Biologic Group
HUALAN BIOLOGICAL ENGINEERING
WEIGUANG BIOLOGICAL
Green Cross
BOHUI
Guangdong Shuanglin Biopharmaceutical
Jiangxi Boya Bio-Pharmaceutical
Frequently Asked Questions
Which is the most lucrative product segment in the Prothrombin Complex Concentrate(PCC) market?
Which are the prominent strategies of the Prothrombin Complex Concentrate(PCC) market players?
Which factors are increasing the competition in the Prothrombin Complex Concentrate(PCC) market?
Which are the recommendations provided by the Prothrombin Complex Concentrate(PCC) industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Prothrombin Complex Concentrate(PCC) market growth?
Which product segment will register the fastest growth rate in the Prothrombin Complex Concentrate(PCC) market?
Which emerging trends will impact the Prothrombin Complex Concentrate(PCC) market growth?
Which are the high-impact rendering factors in the Prothrombin Complex Concentrate(PCC) market?
Which companies will maintain their lead on the Prothrombin Complex Concentrate(PCC) market?
Summary:
Get latest Market Research Reports on Prothrombin Complex Concentrate(PCC). Industry analysis & Market Report on Prothrombin Complex Concentrate(PCC) is a syndicated market report, published as Global Prothrombin Complex Concentrate(PCC) Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Prothrombin Complex Concentrate(PCC) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.